Company Filing History:
2 out of 891 
2 out of 13 
2 out of 6 Years Active: 2020-2022
Title: Isabelle Heard: Innovator in Papillomavirus Research
Introduction
Isabelle Heard is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in understanding papillomavirus and its association with cancer. With a total of 2 patents, her work has the potential to impact cancer prognosis and treatment.
Latest Patents
Isabelle Heard's latest patents focus on the "Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages." This invention provides compositions, kits, and methods for determining the levels of expression of human polyoma or papillomavirus species and RNA transcripts. These levels can be used for the prognosis of the risk of developing virally-induced cancers. The ratio (R) between early and late transcripts is indicative of HPV infections associated with a higher risk of developing genital neoplasia and cancer.
Career Highlights
Throughout her career, Isabelle has worked with esteemed institutions such as Institut Pasteur and École Nationale Vétérinaire d'Alfort. Her research has been pivotal in advancing the understanding of viral infections and their implications for human health.
Collaborations
Isabelle has collaborated with notable colleagues, including Marc Eloit and Nicolas Torno. These partnerships have enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Isabelle Heard's innovative work in papillomavirus research exemplifies her commitment to improving cancer prognosis through scientific discovery. Her contributions are invaluable to the medical community and continue to pave the way for future advancements.